Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma

NCT03388372 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

BIOLOGICAL: Nimotuzumab
DRUG: Temozolomide
RADIATION: Radiotherapy

Sponsor

Biotech Pharmaceutical Co., Ltd.

Collaborators

[object Object]